多草药Unani配方对高血压患者左心室静脉功能障碍的影响 - 一个随机的单盲安慰剂控制的临床试验
Asia Khanum1, Javed Ali Khan2, Arisha Shahid3
1Department of Moalajat, Rehbar Ayurvedic & Unani Tibbi Medical College Hospital and Research Centre, Sangrur, Punjab, India.
Drug metabolism and personalized therapy
|August 13, 2024
概括
一种Unani配方显著改善了左心室的透缩功能,并减少了透缩功能障碍患者的呼吸障碍和疲劳等症状. 需要进一步的研究来确认长期疗效和最佳治疗策略.
科学领域:
- 综合医学是一个整体的医学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 扩张功能障碍是将高血压与心力衰竭联系起来的关键因素,心力衰竭的患病率上升,心力衰竭的喷射分数保留 (HFpEF).
- 高粉带来了显著的发病率和死亡率风险,但基于证据的治疗方法和临床试验仍然有限.
- 这项研究通过研究Unani配方来解决对透缩功能障碍有效治疗的需求.
研究的目的:
- 评估多草药Unani配方在改善左心室扩张功能方面的疗效.
- 评估Unani配方对与腹功能障碍相关的症状的影响,如呼吸障碍和疲劳.
主要方法:
- 一个随机的,安慰剂控制的临床试验进行了35名参与者 (18测试,17控制).
- 试验组接受了Unani配方和*Borago officinalis*提取物八周.
- 对照组接受了安慰剂,每15天进行一次随访,以监测主观和客观参数.
主要成果:
- 与安慰剂相比,Unani配方显示出呼吸障碍和透气功能的显著改善 (p<0.05).
- 在易于疲劳方面观察到非常显著的改善 (p=0.001).
- 在心 (p>0.05) 中观察到轻微但不显著的改善.
结论:
- 乌纳尼配方有效地增强左心室扩张功能,并缓解相关症状.
- 需要进一步的研究和延长的随访,以建立最佳的治疗方案,在Unani医学内治疗腹腔透气功能障碍.
更多相关视频
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.2K
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
3.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
01:22Heart Failure Drugs: Diuretics
353
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353
01:22Heart Failure Drugs: β-Blockers
326
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
01:16Antihypertensive Drugs: Action of Diuretics
642
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
642
01:23Antihypertensive Drugs: Vasodilators
492
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
492
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
140
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
140